The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors
Clinical trial NCT05731934 · COMPLETED
Trial details
- NCT number
- NCT05731934
- Sponsor
- Hangzhou Hanx Biopharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2024-01-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.